Allspring Global Investments Holdings, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$157,540
+0.4%
3,137
+26.3%
0.00%
Q2 2023$156,988
+28.7%
2,484
-8.4%
0.00%
Q1 2023$121,967
+4.7%
2,711
+1.9%
0.00%
Q4 2022$116,534
-34.9%
2,660
-2.2%
0.00%
Q3 2022$179,000
+55.7%
2,719
+19.0%
0.00%
Q2 2022$115,000
-92.9%
2,285
-91.0%
0.00%
-100.0%
Q1 2022$1,628,000
-52.6%
25,495
-20.5%
0.00%
-50.0%
Q4 2021$3,435,00032,0710.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders